Develops biofabricated human tissues and organoid models as an alternative to animal testing for pharma and cosmetics.
| Date | Round | Amount |
|---|---|---|
| Jun 2026 | Funding round Biodimension raised ₹8 Cr (~$0.9M) in a round led by IAN Angel Fund for product development and lab infrastructure. | $920K |
Tap an investor to see what else they have backed.
Data is community-curated and may be incomplete.